Miscellaneous
fromHarvard Gazette
16 hours agoHope for hard-to-treat heart disease
Harvard researchers discovered a method to extend relaxin's duration in the body, potentially enabling effective treatment for heart failure with preserved ejection fraction affecting 1 million U.S. patients.